Should Zelen pre-randomised consent designs be used in some neonatal trials?
My aim is to suggest that there is a case for using a randomised consent design in some neonatal trials. As an example I use the trials of extracorporeal membrane oxygenation (ECMO) in neonates suffering pulmonary hypertension. In some trials the process of obtaining consent has the potential to har...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
1999
|
In: |
Journal of medical ethics
Year: 1999, Volume: 25, Issue: 4, Pages: 325-329 |
Online Access: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
LEADER | 00000caa a22000002 4500 | ||
---|---|---|---|
001 | 1816118532 | ||
003 | DE-627 | ||
005 | 20230427025701.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220908s1999 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/jme.25.4.325 |2 doi | |
035 | |a (DE-627)1816118532 | ||
035 | |a (DE-599)KXP1816118532 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
084 | |a 1 |2 ssgn | ||
100 | 1 | |a Allmark, P. |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Should Zelen pre-randomised consent designs be used in some neonatal trials? |
264 | 1 | |c 1999 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a My aim is to suggest that there is a case for using a randomised consent design in some neonatal trials. As an example I use the trials of extracorporeal membrane oxygenation (ECMO) in neonates suffering pulmonary hypertension. In some trials the process of obtaining consent has the potential to harm the subject, for example, by disappointing those who end in the control group and by creating additional anxiety at times of acute illness. An example of such were the trials of extracorporeal membrane oxygenation (ECMO) in neonates suffering pulmonary hypertension. Pre-randomised consent could avoid or lessen these harms. However, a number of ethical objections are made to these research designs. They involve denial of information, using people, denial of choice, and "overselling" of allocated treatment. Furthermore, they are the wrong response; better communication might be the answer, for example. I argue that these objections are not completely persuasive. However, they are enough to suggest caution in the use of such designs. | ||
773 | 0 | 8 | |i Enthalten in |t Journal of medical ethics |d London : BMJ Publ., 1975 |g 25(1999), 4, Seite 325-329 |h Online-Ressource |w (DE-627)323607802 |w (DE-600)2026397-1 |w (DE-576)260773972 |x 1473-4257 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:1999 |g number:4 |g pages:325-329 |
856 | |3 Volltext |u http://www.jstor.org/stable/27718330 |x JSTOR | ||
856 | |u https://jme.bmj.com/content/medethics/25/4/325.full.pdf |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [open (via free pdf)] | ||
856 | 4 | 0 | |u https://doi.org/10.1136/jme.25.4.325 |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u http://jme.bmj.com/content/25/4/325.abstract |x Verlag |z kostenfrei |3 Volltext |
935 | |a mteo | ||
936 | u | w | |d 25 |j 1999 |e 4 |h 325-329 |
951 | |a AR | ||
ELC | |a 1 | ||
ITA | |a 1 |t 1 | ||
LOK | |0 000 xxxxxcx a22 zn 4500 | ||
LOK | |0 001 4185570422 | ||
LOK | |0 003 DE-627 | ||
LOK | |0 004 1816118532 | ||
LOK | |0 005 20220908053301 | ||
LOK | |0 008 220908||||||||||||||||ger||||||| | ||
LOK | |0 035 |a (DE-Tue135)IxTheo#2022-08-02#5EF01877A1BDC1B1A365B840EA12586294D42C23 | ||
LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
LOK | |0 092 |o n | ||
LOK | |0 852 |a DE-Tue135 | ||
LOK | |0 852 1 |9 00 | ||
LOK | |0 866 |x JSTOR#http://www.jstor.org/stable/27718330 | ||
LOK | |0 935 |a ixzs |a ixrk |a zota | ||
OAS | |a 1 | ||
ORI | |a SA-MARC-ixtheoa001.raw |